PNC Financial Services Group
ELDN icon

PNC Financial Services Group’s Eledon Pharmaceuticals ELDN Stock Holding History

PNC Financial Services Group’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.89K Buy
937
+932
+18,640% +$2.19K ﹤0.01% 4471
2025
Q4 		$8 Sell
5
-4
-44% -$10 ﹤0.01% 5142
2025
Q3 		$23 Buy
+9
New +$26 ﹤0.01% 5056

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

PNC Financial Services Group's ELDN Position: Q1 2026 in Review

PNC Financial Services Group increased its Eledon Pharmaceuticals (ELDN) stake by 18,640% in Q1 2026, buying an estimated $2.19K and bringing the position to 937 shares worth $2.89K. The position accounts for ﹤0.01% of the portfolio, ranked #4471.

PNC Financial Services Group first reported a position in ELDN in Q3 2025 and has held it in 3 quarters since. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • PNC Financial Services Group held 937 shares of Eledon Pharmaceuticals worth $2.89K as of Q1 2026.
  • PNC Financial Services Group bought 932 Eledon Pharmaceuticals shares in Q1 2026, an estimated $2.19K.
  • Eledon Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4471 holding.
  • PNC Financial Services Group first reported a position in Eledon Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.